Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrainline Regulatory News (TRN)

Share Price Information for Trainline (TRN)

Share Price is delayed by 15 minutes
Get Live Data
214.00    -4.40 (-2.01%)
Bid:
214.20
Ask:
214.80
Spread: 0.60 (0.28%)
Market Cap: £755.88m
TRN Live PriceLast checked at - London Stock Exchange

Intraday Trainline Share Chart

Stabilisation Notice

21 Jun 2019 07:06

RNS Number : 0073D
Morgan Stanley & Co. Int'l plc
21 June 2019
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Trainline plc

Stabilisation Notice

21/06/19

Morgan Stanley & Co. International plc (contact: James Manson-Bahr; telephone: +44 20 7425-3672) hereby gives notice, as Stabilisation Manager, that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014.

 

The securities:

Issuer:

Trainline plc

Securities:

Ordinary shares ("Shares") of the Issuer (ISIN: GB00BKDTK925)

Offer size:

271,655,470 ("Offer Shares") (excluding the over-allotment option)

Offer price:

350 pence

Stabilisation:

Stabilising Manager(s):

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA

Stabilisation period expected to start on:

Friday 21st June 2019

Stabilisation period expected to end no later than:

Friday 19th July 2019

Maximum size of over-allotment facility:

Up to 40,748,321 shares

Stabilisation trading venue:

London Stock Exchange

Over-allotment Option:

Terms:

KKR Victoria Aggregator L.P. has granted Morgan Stanley & Co. International plc, in its capacity as stabilisation manager, and for the account of the underwriters, the option to acquire up to an additional 40,748,321 Shares at the Offer Price (representing up 15 per cent of the Offer size).

Duration:

This option may be executed at any time during the stabilisation period.

 

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

END.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAFBMFTMBMTMJL
Date   Source Headline
1st Aug 20229:00 amRNSDirector Declaration
27th Jul 202211:00 amRNSNew Revolving Credit Facility
15th Jul 20222:19 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSReminder of product innovation webinar event
6th Jul 20227:00 amRNSTrading update
30th Jun 20224:12 pmRNSDirector/PDMR Shareholding
30th Jun 20222:15 pmRNSResult of AGM
28th Jun 202211:14 amRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSDirectorate Change
16th Jun 20229:00 amRNSNotice of investor webinar – Product innovation
31st May 202211:00 amRNSAnnual Financial Report
24th May 202210:00 amRNSDirectorate Change
23rd May 20229:30 amRNSHolding(s) in Company
20th May 20222:30 pmRNSDirector/PDMR Shareholding
11th May 20221:06 pmRNSNotification of repurchase of convertible bonds
5th May 20227:00 amRNSResults for the twelve months ended 28 Feb 2022
26th Apr 20222:08 pmRNSForm 8.3 - Trainline PLC
11th Apr 20223:03 pmRNSHolding(s) in Company
31st Mar 20227:00 amRNSAmendment to Trainline’s 3rd party retail licence
29th Mar 20224:37 pmRNSHolding(s) in Company
17th Mar 20224:51 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSTRADING STATEMENT AND NOTICE OF FULL YEAR RESULTS
10th Mar 20221:47 pmRNSNotification of repurchase of convertible bonds
9th Mar 20229:25 amRNSHolding(s) in Company
7th Mar 20222:26 pmRNSHolding(s) in Company
22nd Feb 20229:30 amRNSCommittee Change
7th Feb 20227:00 amRNSNotification of repurchase of convertible bonds
27th Jan 202210:24 amRNSHolding(s) in Company
24th Jan 20229:34 amRNSHolding(s) in Company
24th Jan 20229:34 amRNSHolding(s) in Company
21st Jan 20222:53 pmRNSHolding(s) in Company
8th Dec 20213:50 pmRNSHolding(s) in Company
12th Nov 202110:32 amRNSHolding(s) in Company
3rd Nov 20217:00 amRNSResults for the six months ended 31 August 2021
14th Sep 20217:00 amRNSTrading statement and notice of Half Year results
27th Aug 20214:25 pmRNSDirector/PDMR Shareholding
27th Aug 20213:30 pmRNSDirector Declaration
27th Aug 20211:42 pmRNSHolding(s) in Company
6th Aug 20217:00 amRNSNotification of Repurchase of Convertible Bonds
14th Jul 20219:00 amRNSHolding(s) in Company
5th Jul 20213:27 pmRNSHolding(s) in Company
1st Jul 202112:30 pmRNSResult of AGM
28th Jun 202111:51 amRNSHolding(s) in Company
24th Jun 20219:56 amRNSHolding(s) in Company
17th Jun 20217:00 amRNSTrainline Q1 FY2022 trading statement
1st Jun 20214:16 pmRNSDirector/PDMR Shareholding
1st Jun 20214:15 pmRNSAnnual Financial Report
28th May 20219:30 amRNSDirector/PDMR Shareholding
26th May 20212:30 pmRNSDirector/PDMR Shareholding
21st May 20211:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.